Y1 receptor ligand-based nanomicelle as a novel nanoprobe for glioma-targeted imaging and therapy-Reference-Cited by-同舟云学术

Y1 receptor ligand-based nanomicelle as a novel nanoprobe for glioma-targeted imaging and therapy

Published:2018 Issue:13 Volume:10 Page:5845-5851
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Li Juan¹²³⁴⁵,Du Yang⁶⁷⁸⁵⁹,Jiang Zhenqi¹²³⁴⁵,Tian Yuchen¹²³⁴⁵,Qiu Nianxiang¹²³⁴⁵,Wang Yinjie¹²³⁴⁵,lqbal Muhammad Zubair¹²³⁴⁵,Hu Menying¹²³⁴⁵,Zou Ruifen¹²³⁴⁵,Luo Lijia¹²³⁴⁵,Du Shiyu¹²³⁴⁵^ORCID,Tian Jie⁶⁷⁸⁵⁹,Wu Aiguo¹²³⁴⁵^ORCID

Affiliation:

1. CAS Key Laboratory of Magnetic Materials and Devices

2. Key Laboratory of Additive Manufacturing Materials of Zhejiang Province

3. and Division of Functional Materials and Nanodevices

4. Ningbo Institute of Materials Technology and Engineering

5. Chinese Academy of Sciences

6. CAS Key Laboratory of Molecular Imaging

7. The Sate Key Laboratory of Management and Control for Complex Systems

8. Institution of Automation

9. Beijing 100190

Abstract

Y₁ receptor ligand AP-NPY facilitates circumvention of the blood brain barrier by nanomicelles specifically targeting glioma, improving therapeutic efficacy and prolonging survival.

Funder

National Natural Science Foundation of China

Science and Technology Department of Zhejiang Province

Natural Science Foundation of Guangdong Province

Youth Innovation Promotion Association of the Chinese Academy of Sciences

Chinese Academy of Sciences

Ningbo Municipal Bureau of Science and Technology

University of Science and Technology Beijing

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science